Results 121 to 130 of about 12,579 (242)
Memorias do Instituto Oswaldo Cruz, 2001 CD8+ T cells have been implicated as critical effector cells in protection against the pre-erythrocytic stage of malaria in mice and humans following irradiated sporozoite immunization.
J Oliveira-Ferreira, CT Daniel-Ribeiro
doaj +1 more source
The development of an AIDS mucosal vaccine [PDF]
, 2010 It is well known that mucosal tissues contain the largest surface area of the human body and are the front line of natural host defense against various pathogens.
Chen, Z, Tang, X
core +3 more sources
High Cell Density Perfusion Process of Quail Cells Producing Oncolytic rVSV‐NDV
Engineering in Life Sciences, Volume 25, Issue 7, July 2025.ABSTRACT Oncolytic viruses as agents for the treatment of various types of cancer have demonstrated their potential in many clinical studies over the past decades. In particular, rVSV‐NDV (a recombinant vesicular stomatitis virus [VSV] construct with fusogenic Newcastle disease virus glycoproteins) shows promising preclinical results.
Lennart Jacobtorweihe +5 more
wiley +1 more source
Vaccines, 2014 Viral vectors are promising tools for vaccination strategies and immunotherapies. However, CD8+ T cell responses against pathogen-derived epitopes are usually limited to dominant epitopes and antibody responses to recombinant encoded antigens (Ags) are ...
Pablo D. Becker +6 more
doaj +1 more source
Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infection [PDF]
, 2020 Delphine C. Malherbe +7 more
openalex +1 more source
MNF, an ankyrin repeat protein of myxoma virus, is part of a native cellular SCF complex during viral infection [PDF]
, 2010 Myxoma virus (MYXV), a member of the Poxviridae family, is the agent responsible for myxomatosis, a fatal disease in the European rabbit (Oryctolagus cuniculus).
Bertagnoli, Stéphane +3 more
core +6 more sources
Viruses, 2018 The highly attenuated Modified Vaccinia virus Ankara (MVA) lacks most of the known vaccinia virus (VACV) virulence and immune evasion genes. Today MVA can serve as a safety-tested next-generation smallpox vaccine.
Asisa Volz +5 more
doaj +1 more source
Development of vaccines for HIV-1: relevance of subtype-specific cellular immunity [PDF]
, 2010 Han pasado casi 30 años de la detección de los primeros casos de infección con HIV-1 y aún no se ha conseguido desarrollar una vacuna efectiva y segura.
Falivene, Juliana +4 more
core
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants. [PDF]
, 2016 Malaria remains a significant global health burden and a vaccine would make a substantial contribution to malaria control. Chimpanzee Adenovirus 63 Modified Vaccinia Ankara Multiple epitope thrombospondin adhesion protein (ME-TRAP) and vaccination has ...
Adetifa, Uche J +31 more
core +3 more sources